News
CSW Group
Pharmaceutical
There is a critical need for consistency and accuracy in the production of medical and drug related information, where inaccuracies can cost lives.
CSW’s Knowledge Management Suite (KMS) is ideally suited to the management of large volumes of highly-structured technical drug documentation. It facilitates an enterprise-wide review process, supports collaborative working on content components and enables publishing on demand to multiple formats.
In the highly competitive pharmaceutical industry, speed and efficiency are crucial for drug development. KMS aims to optimise the transfer, storage, use, and reuse of critical knowledge between stakeholders in the pharmaceutical industry in order to dramatically decrease costs and improve efficiency. It also facilitates the delivery of information in standards-based formats to conform to emerging XML-based regulatory guidelines, including Product Information Management (PIM) and Structured Product Labelling (SPL).
Within pharmaceutical research and development (R&D), optimizing processes via knowledge management using KMS can have profound effects. Knowledge-driven drug development can be used in clinical trial simulation to increase the chances of success and limit the number of clinical studies. Enabling providers to deliver high quality medical and drug related information reduces the risk of litigation and regulatory non-compliance and knowledge management can be used to optimise the R&D value chain with workflow management in areas like regulatory claim submission.
